clotrimazole has been researched along with Recrudescence in 52 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Initial successful therapy with 2% clotrimazole topically, to which it was sensitive, was followed by recurrent infection after 39 months, initially a keratitis but progressing to an endophthalmitis." | 3.68 | Sphaeropsis subglobosa keratomycosis--first reported case. ( Clayton, YM; Kirkness, CM; Punithalingam, E; Seal, DV, 1991) |
| "A self-medication therapy with clotrimazole vaginal tablets, application of two tablets at bedtime on 3 consecutive days, was carried out to find out whether vulvo-vaginal mycoses can be treated more effectively and with fewer drop-outs when treatment is simpler and shorter." | 3.66 | Three-day clotrimazole therapy for vulvo-vaginal mycosis. ( Higashide, K; Kawaguchi, C; Tomoda, Y, 1983) |
| "All consecutive patients with pityriasis versicolor were included and randomly divided into two groups." | 2.75 | Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. ( Akbari, N; Alborzi, N; Dehghan, M; Keshtkar, AA; Sadani, S, 2010) |
| "The cumulative recurrence frequency after 6 months intermittent prophylaxis with clotrimazole (30." | 2.67 | Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. ( Forssman, L; Milsom, I; Roth, AC; Wåhlén, P, 1990) |
| "Of 30 women given such treatment, 13 relapsed within three months." | 2.66 | Intermittent local prophylaxis against recurrent vaginal candidosis. ( Bushell, TE; Evans, EG; Meaden, JD; Milne, JD; Warnock, DW, 1988) |
| "The incidences of recurrence/reinfection and treatment failures were comparable in the two groups." | 2.65 | A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use. ( Ford, LC; Goldman, L; Lebherz, TB; Mason, D; Wiesmeier, E, 1983) |
| "The high rate of recurrence of this condition is noted and the need for at least 6 months' follow-up in future trials of candidacides is emphasized." | 2.65 | Vulvovaginal candidiasis: treatment and recurrence. ( Dennerstein, GJ; Langley, R, 1982) |
| "Vulvovaginal candidiasis is considered recurrent when at least four specific episodes occur in one year or at least three episodes unrelated to antibiotic therapy occur within one year." | 2.41 | Treatment of recurrent vulvovaginal candidiasis. ( Ringdahl, EN, 2000) |
| "Adjusted free-survival recurrence was 72." | 1.43 | Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). ( Espadaler, J; Fernández-Moya, JM; Palacios, S; Prieto, C; Salas, N, 2016) |
| "Recurrence is a frequent complaint of patients with vulvovaginal candidiasis (VVC)." | 1.40 | Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. ( Banco, R; De Leo, R; De Santo, D; De Seta, F; Inglese, S; Maso, GP; Parazzini, F; Restaino, S; Sartore, A; Stabile, G; Tonon, M, 2014) |
| "We present a case of an invasive squamous cell carcinoma of the glans penis, which was treated with topical antifungals and corticosteroids for 2 years prior to diagnosis, necessitating partial glansectomy." | 1.39 | Squamous cell carcinoma of the penis and topical combination corticosteroid products: a cautionary case. ( Aires, D; Blackmon, J; Laarman, R; Rajpara, A, 2013) |
| "Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women." | 1.31 | An investigation into the pathogenesis of vulvo-vaginal candidosis. ( Ashbee, HR; Barton, RC; El-Din, SS; Evans, EG; Reynolds, MT, 2001) |
| "No further recurrences occurred during 14 months' follow-up." | 1.28 | Acanthamoeba keratitis--resistance to medical therapy. ( Ficker, L; Seal, D; Warhurst, D; Wright, P, 1990) |
| "The miconazole tampons were highly acceptable to patients." | 1.26 | Comparison of miconazole-coated tampons with clotrimazole vaginal tablets in the treatment of vaginal candidosis. ( Balsdon, MJ, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (40.38) | 18.7374 |
| 1990's | 16 (30.77) | 18.2507 |
| 2000's | 8 (15.38) | 29.6817 |
| 2010's | 7 (13.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, HY | 1 |
| Feng, D | 1 |
| Wei, DM | 1 |
| Mei, L | 1 |
| Chen, H | 1 |
| Wang, X | 1 |
| Fang, F | 1 |
| Genovese, C | 1 |
| Cianci, A | 1 |
| Corsello, S | 1 |
| Ettore, G | 1 |
| Mattana, P | 1 |
| Tempera, G | 1 |
| Laarman, R | 1 |
| Blackmon, J | 1 |
| Rajpara, A | 1 |
| Aires, D | 1 |
| De Seta, F | 1 |
| Parazzini, F | 1 |
| De Leo, R | 1 |
| Banco, R | 1 |
| Maso, GP | 1 |
| De Santo, D | 1 |
| Sartore, A | 1 |
| Stabile, G | 1 |
| Inglese, S | 1 |
| Tonon, M | 1 |
| Restaino, S | 1 |
| Palacios, S | 1 |
| Espadaler, J | 1 |
| Fernández-Moya, JM | 1 |
| Prieto, C | 1 |
| Salas, N | 1 |
| Dehghan, M | 1 |
| Akbari, N | 1 |
| Alborzi, N | 1 |
| Sadani, S | 1 |
| Keshtkar, AA | 1 |
| Davis, JD | 1 |
| Harper, AL | 1 |
| Alston, SJ | 1 |
| Cohen, BA | 1 |
| Braun, M | 1 |
| Schochet, RA | 1 |
| Lappin, MR | 1 |
| Mårdh, PA | 1 |
| Wågström, J | 1 |
| Landgren, M | 1 |
| Holmén, J | 1 |
| Williams, A | 1 |
| Aggarwal, A | 1 |
| Shier, RM | 1 |
| Lebherz, TB | 1 |
| Goldman, L | 1 |
| Wiesmeier, E | 1 |
| Mason, D | 1 |
| Ford, LC | 1 |
| Higashide, K | 1 |
| Kawaguchi, C | 1 |
| Tomoda, Y | 1 |
| Burmucic, R | 1 |
| Kowatsch, A | 1 |
| Granitzka, S | 1 |
| Dennerstein, GJ | 1 |
| Langley, R | 1 |
| Balsdon, MJ | 1 |
| Sobel, JD | 3 |
| Brooker, D | 1 |
| Stein, GE | 1 |
| Thomason, JL | 1 |
| Wermeling, DP | 1 |
| Bradley, B | 1 |
| Weinstein, L | 1 |
| Elewski, B | 2 |
| Bergstresser, PR | 2 |
| Hanifin, J | 2 |
| Lesher, J | 2 |
| Savin, R | 2 |
| Shupack, J | 2 |
| Stiller, M | 2 |
| Tschen, E | 2 |
| Zaias, N | 3 |
| Birnbaum, JE | 2 |
| Schmitt, C | 2 |
| Stein, G | 1 |
| Mummaw, N | 1 |
| Christensen, S | 1 |
| Meriwether, C | 2 |
| Baron, JR | 1 |
| Kelly, RB | 1 |
| Fong, IW | 3 |
| Bannatyne, RM | 1 |
| Wong, P | 1 |
| Finkelstein, DM | 1 |
| Schoenfeld, DA | 1 |
| Stamenovic, E | 1 |
| Nenoff, P | 1 |
| Haustein, UF | 1 |
| Mahé, C | 1 |
| Matthews, P | 1 |
| Drew, SV | 1 |
| Low, L | 1 |
| Ringdahl, EN | 1 |
| Deva, R | 1 |
| Ciccoli, R | 1 |
| Kock, L | 1 |
| Nigam, S | 1 |
| El-Din, SS | 1 |
| Reynolds, MT | 1 |
| Ashbee, HR | 1 |
| Barton, RC | 1 |
| Evans, EG | 3 |
| Davidson, F | 1 |
| Mould, RF | 1 |
| Aufdemorte, TB | 1 |
| McPherson, MA | 1 |
| Milne, JD | 3 |
| Warnock, DW | 3 |
| Emokpare, NA | 1 |
| Eliot, BW | 1 |
| Howat, RC | 1 |
| Mack, AE | 1 |
| Battistini, F | 1 |
| Gomez-Urcuyo, F | 1 |
| Rojas, RF | 1 |
| Ricart, R | 1 |
| Kirkness, CM | 1 |
| Seal, DV | 1 |
| Clayton, YM | 1 |
| Punithalingam, E | 1 |
| Ficker, L | 1 |
| Seal, D | 1 |
| Warhurst, D | 1 |
| Wright, P | 1 |
| Peterson, RJ | 1 |
| Smith, ME | 1 |
| Pepose, JS | 1 |
| Roth, AC | 1 |
| Milsom, I | 3 |
| Forssman, L | 3 |
| Wåhlén, P | 1 |
| Bushell, TE | 2 |
| Meaden, JD | 2 |
| Llewellyn, PA | 1 |
| Senff, H | 1 |
| Bothe, C | 1 |
| Riemann, U | 1 |
| Reinel, D | 1 |
| Takada, M | 1 |
| Kubota, T | 1 |
| Hogaki, M | 1 |
| Okawa, T | 1 |
| Uchida, K | 1 |
| Yamaguchi, H | 1 |
| Cohen, L | 1 |
| Cohen, M | 1 |
| Harkness, RA | 1 |
| Renz, M | 1 |
| Farquhar, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Clinical Trial to Evaluate the Safety, Tolerability and Acceptability of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Female Volunteers[NCT05587283] | Phase 1 | 24 participants (Anticipated) | Interventional | 2022-11-02 | Recruiting | ||
| Interventional Study to Evaluate the Effect of a Food Supplement Comprising L. Plantarum After Oral Intake in Vaginal Microbiota[NCT04461782] | 30 participants (Actual) | Interventional | 2019-04-15 | Completed | |||
| A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001[NCT03115073] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2017-04-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for clotrimazole and Recrudescence
| Article | Year |
|---|---|
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fl | 2017 |
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrim | 2019 |
Selections from current literature: issues in the management of vaginitis.
Topics: Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Female; Humans; Male; Metronidazole; Recur | 1993 |
Recurrent vaginal thrush and soreness.
Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dia | 1999 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; | 2000 |
23 trials available for clotrimazole and Recrudescence
| Article | Year |
|---|---|
Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial.
Topics: Adult; Antifungal Agents; Clinical Protocols; Clotrimazole; Double-Blind Method; Female; Fluconazole | 2010 |
CVV in women with HIV.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Complement | 2005 |
A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.
Topics: Adult; Aged; Candida; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Contracepti | 1983 |
Efficiency of various therapeutic concepts in genital mycoses.
Topics: Clinical Trials as Topic; Clotrimazole; Female; Genital Diseases, Female; Humans; Imidazoles; Mycose | 1982 |
Vulvovaginal candidiasis: treatment and recurrence.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Clotrimazole; Econazole; Fem | 1982 |
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvov | 1995 |
Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.
Topics: Antifungal Agents; Clotrimazole; Double-Blind Method; Follow-Up Studies; Humans; Longitudinal Studie | 1995 |
Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, V | 1994 |
The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Cost-Benefit Analysis; Drug Costs; Femal | 1994 |
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazol | 1993 |
Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Clinical Protocols; Clotrimazole; Double-Blind | 1993 |
Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1978 |
Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1979 |
[Clinical experiences with clotrimazole in treating vaginal candidiasis].
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Femal | 1979 |
A comparison between the effects of nystatin, clotrimazole and miconazole on vaginal candidiasis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Evaluation Studies as Topic; Female; Hum | 1979 |
Treatment of "tinea pedis" with griseofulvin and topical antifungal cream.
Topics: Administration, Topical; Clotrimazole; Drug Therapy, Combination; Follow-Up Studies; Griseofulvin; H | 1978 |
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; | 1992 |
Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Colony Count, Microbia | 1990 |
Clotrimazole treatment of recurrent and chronic candida vulvovaginitis.
Topics: Adult; Candidiasis, Vulvovaginal; Chronic Disease; Clinical Trials as Topic; Clotrimazole; Double-Bl | 1989 |
Intermittent local prophylaxis against recurrent vaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans | 1988 |
Prophylactic use of clotrimazole in recurrent vaginal candidosis.
Topics: Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles | 1988 |
Is more than one application of an antifungal necessary in the treatment of acute vaginal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole | 1985 |
Trials of the use of clotrimazole in the treatment of oral candidiasis in newborn babies.
Topics: Birth Weight; Candidiasis, Oral; Clinical Trials as Topic; Clotrimazole; Humans; Imidazoles; Infant, | 1974 |
24 other studies available for clotrimazole and Recrudescence
| Article | Year |
|---|---|
Squamous cell carcinoma of the penis and topical combination corticosteroid products: a cautionary case.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Betamethasone; Carcinoma, Squamous Cell; | 2013 |
Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotr | 2014 |
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Lacto | 2016 |
FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cl | 2011 |
Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents.
Topics: Administration, Topical; Allylamine; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Chi | 2003 |
Delayed recurrence of nasal aspergillosis in a dog.
Topics: Animals; Antifungal Agents; Aspergillosis; Clotrimazole; Dog Diseases; Dogs; Dose-Response Relations | 2005 |
Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Databases as Topic; D | 2004 |
Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification.
Topics: Acetic Acid; Adult; Animals; Anti-Infective Agents, Local; Antiprotozoal Agents; Boric Acids; Clotri | 2008 |
Three-day clotrimazole therapy for vulvo-vaginal mycosis.
Topics: Adult; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Evaluation; Female; Humans; Imidazoles | 1983 |
[Treatment results after a single local application of 500 mg of clotrimazole in vaginal mycoses during pregnancy].
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Hu | 1984 |
Comparison of miconazole-coated tampons with clotrimazole vaginal tablets in the treatment of vaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Miconazole; | 1981 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Clinical Trials, Phase III as | 1997 |
Tinea corporis due to Trichophyton tonsurans Malmsten--report of a patient from Zaire.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Betamethasone; Clotrimazole | 1997 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis; | 1998 |
Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis.
Topics: Antifungal Agents; Arachidonic Acids; Aspirin; Candida albicans; Candidiasis, Vulvovaginal; Clotrima | 2001 |
An investigation into the pathogenesis of vulvo-vaginal candidosis.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance | 2001 |
Refractory oral candidiasis. Report of a case.
Topics: Administration, Oral; Candida albicans; Candidiasis, Oral; Clotrimazole; Drug Resistance, Microbial; | 1978 |
Sphaeropsis subglobosa keratomycosis--first reported case.
Topics: Aged; Clotrimazole; Corneal Stroma; Eye Injuries, Penetrating; Humans; Keratitis; Keratoplasty, Pene | 1991 |
Acanthamoeba keratitis--resistance to medical therapy.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Arsenicals; Benzamidines; Benzethonium; Clotrim | 1990 |
Recurrent Acanthamoeba keratitis following penetrating keratoplasty.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Clotrimazole; Corneal Stroma; Female; Humans; | 1990 |
[Local therapy of pityriasis versicolor with 3 imidazole derivatives--results of a therapeutic study. Studies of the rate of recurrence].
Topics: Administration, Topical; Adult; Clotrimazole; Econazole; Follow-Up Studies; Humans; Imidazoles; Male | 1988 |
Attributes of microorganisms that contribute to recurrence and intractability of vaginal mycosis.
Topics: Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Microbial; Female; Humans; Recurr | 1986 |
Treatment of recurrent vaginal candidiasis.
Topics: Administration, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Male; Pat | 1985 |
Repeated candidiasis: reinfection or recrudescence? A review.
Topics: Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clothing; Clotrimazole; Contraceptives, Oral; Diab | 1985 |